Showing results (1-10 of 118) with videos related to
Sort By:
Pageof 12
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
Role of Molecular Pathology in the Treatment of Anaplastic Gliomas and GlioblastomasMatthias HoldhoffThe Oncologist|February 23, 2011
Controversies in the adjuvant therapy of high-grade gliomasMatthias Holdhoff, Stuart A GrossmanJournal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Controversies in the treatment of elderly patients with newly diagnosed glioblastomaMatthias Holdhoff, Marc C ChamberlainCNS Oncology|July 24, 2014
Emerging methods for disease monitoring in malignant gliomasPrakash Ambady, Chetan Bettegowda, Matthias HoldhoffOncotargets and Therapy|September 9, 2020
Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment StrategiesMatthias Holdhoff, Nina Wagner-Johnston, Mark RoschewskiTrends in Cancer|June 13, 2017
Actionable molecular biomarkers in primary brain tumorsVerena Staedtke, Omar Dildar a Dzaye, Matthias HoldhoffOncology (Williston Park, N.Y.)|December 17, 2014
Chemotherapy for treatment of grade II gliomasRoy E Strowd, Matthias Holdhoff, Stuart A GrossmanOncotarget|November 1, 2011
Systemic use of tumor necrosis factor alpha as an anticancer agentNicholas J Roberts, Shibin Zhou, Luis A Diaz, et al.Journal of Neuro-Oncology|May 15, 2013
Blood-based biomarkers for malignant gliomasMatthias Holdhoff, Susannah G Yovino, Osei Boadu, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Evolving Treatments for Primary Central Nervous System LymphomaAndrés J M Ferreri, Matthias Holdhoff, Lakshmi Nayak, et al.Pageof 12